Introduction
============

Macular hole-associated retinal detachment (MHRD) occurs most commonly in myopic eyes and is an intractable form of retinal detachment.^[@bib1],\ [@bib2],\ [@bib3]^ Several approaches have been attempted such as macular buckling, scleral shortening, pars plana vitrectomy (PPV), and combinations thereof.^[@bib4],\ [@bib5],\ [@bib6]^ The macular buckling technique was the standard surgical treatment for MHRD before the introduction of PPV in 1982.^[@bib2],\ [@bib7],\ [@bib8],\ [@bib9]^ The retinal attachment rate after macular buckling and scleral shortening ranged from 93.3 to 100%, although the macular hole closure rates after these procedures were unknown.^[@bib4]^ Since then, PPV has gained popularity with several additional procedures such intraocular gas or silicon oil tamponade,^[@bib10],\ [@bib11],\ [@bib12]^ laser photocoagulation of the macular hole rim,^[@bib12]^ and internal limiting membrane (ILM) peeling.^[@bib13],\ [@bib14],\ [@bib15]^ The retinal reattachment rates after these initial surgeries ranged from 42.8 to 92.3%.^[@bib13],\ [@bib16],\ [@bib17],\ [@bib18],\ [@bib19]^ Previous reports showed that the macular hole closure rate using optical coherence tomography (OCT) after PPV ranged from 10 to 91%.^[@bib13],\ [@bib15]^ These anatomic success rates were variable and not always greater than in cases of non-macular hole-related rhegmatogenous retinal detachment and idiopathic macular hole. Therefore, the basic surgical management of MHRD has not been clarified.

Recently, Michalewska *et al*^[@bib20]^ have reported the efficacy of the ILM flap technique for large macular holes. Kuriyama and Michalewska *et al*^[@bib21],\ [@bib22]^ also found that the inverted ILM flap technique contributed to a high macular hole closure rate in highly myopic eyes. We therefore hypothesized that the inverted ILM flap technique would be an effective treatment for MHRD. The aim of this study was to determine whether the technique could contribute to high reattachment and closure rates in patients with MHRD.

Patients and methods
====================

This study protocol was approved by St Marianna University Hospital and adhered to the tenets of the Declaration of Helsinki. We reviewed the medical records of consecutive patients who had MHRD and were treated by PPV with the inverted ILM flap technique or ILM peeling at St Marianna University Hospital, Kurihara Eye Hospital, and Otake Eye Clinic between October 2009 and October 2013. Between October 2009 and April 2013, the consecutive patients underwent PPV with ILM peeling. From May 2013, the inverted ILM flap technique was performed in consecutive patients. Before and after surgery, all patients underwent a through ocular examination, including determination of axial length and visual acuity, and biomicroscopy of the posterior segment using a slit lamp with a 90 D lens. The preoperative diagnosis and postoperative anatomic status of MHRD were examined using OCT. High myopia was defined as an axial length \>27 mm. Staphyloma was defined as ectasia in the posterior pole detected in OCT. The best-corrected visual acuity (BCVA) was measured using the Landolt C acuity test and converted to a logarithm of minimal angle of resolution for statistical analysis. The follow-up period was at least 6 months after the final surgery. Exclusion criteria were a history of trauma, choroidal neovascularization, and the presence of a peripheral retinal break or proliferative vitreoretinopathy before the initial surgery.

A standard 25-gauge PPV and phacoemulsification with intraocular lens implantation was performed in eyes that had cataracts, and vitrectomy alone was performed in pseudophakic eyes and eyes without cataracts. Triamcinolone acetonide was used intraoperatively to facilitate visualization of the vitreous and posterior hyaloids in all eyes. Subsequently, the inverted ILM flap technique was performed in six eyes. ILM peeling and removal were performed in nine eyes. For better visibility, we stained the ILM with a solution of brilliant blue G (BBG), as described by Enaida *et al*^[@bib23]^ The inverted ILM flap technique was basically performed according to the method of Michalewska *et al*^[@bib20]^ To stabilize the ILM flap, we placed a Viscoat ophthalmic viscosurgical device (sodium chondroitin sulfate-sodium hyaluronate; Alcon Laboratories, Inc., Fort Worth, TX, USA) on the inverted ILM. Fluid--air exchange up to the staphyloma margin or slightly above the upper margin of the detached retina was performed if the retinal detachment was localized within the arcade. When the retinal detachment extended to or beyond the equator, drainage of subretinal fluid was performed through the retinal hole intentionally created outside the macular hole in patients undergoing the inverted ILM flap technique and through the macular hole in patients undergoing ILM peeling. In all patients, the air was then replaced with nonexpansive gas, either perfluoropropane or sulfur hexafluoride. Each patient was asked to maintain a facedown position postoperatively for at least 5 days.

All procedures were performed by a single surgeon (HT). To evaluate the efficacy of the inverted ILM flap technique for MHRD, the patients were divided into two groups based on the surgical procedure: the inverted ILM flap technique group (group 1) and ILM peeling group (group 2). The BCVA and retinal attachment and macular hole closure rates were compared between the two groups before and after surgery.

Statistical analyses were performed using StatView software (Abacus Concepts, Inc., Berkeley, CA, USA, 1992). The Wilcoxon rank-sum test was used to compare pre- and postoperative BCVA. The *χ*^2^-test was used to compare retinal attachment and macular hole closure rates. The comparison of BCVA in the two groups was analyzed in the Mann--Whitney *U*-test. A *P*-value of \<0.05 was considered to represent a statistically significant difference.

Results
=======

Patient characteristics are shown in [Table 1](#tbl1){ref-type="table"}. In all, 12 women (80%) and 3 men (20%) were included in this study. The patient ages at the initial surgery ranged from 46 to 82 (mean 69.6±11.2) years. All patients had staphyloma. [Table 2](#tbl2){ref-type="table"} shows a comparison of preoperative patient demographic data. Group 1 included 6 eyes of 6 patients in whom vitrectomy combined with the inverted ILM flap technique was performed, and group 2 included 9 eyes of 9 patients in whom vitrectomy combined with ILM peeling for MHRD was performed ([Figure 1](#fig1){ref-type="fig"}). The duration of symptoms, age, axial length, and preoperative BCVA did not differ significantly between them (*P*\>0.05, respectively). Secondary surgery was performed in 3 eyes in group 2, and 1 patient refused secondary surgery ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}).

Postoperative ophthalmic data are shown in [Table 3](#tbl3){ref-type="table"}. No significant differences were found in the postoperative BCVA at 1 and 3 months after surgery in both groups (*P*\>0.05, respectively). The postoperative BCVA at 6 months after surgery was significantly better in group 1 than in group 2 (*P*=0.045). The improvement of BCVA was significantly better in group 1 than in group 2 (*P*=0.021). The primary macular hole closure rates were 100% in group 1 and 55.5% in group 2 (*P*=0.056). The final macular hole closure rates were 88.8% in group 2. There was no significant difference in both groups (*P*=0.398). The primary reattachment rates were 100% in group 1 and 55.5% in group 2 (*P*=0.056). The final reattachment rates were 100% in group 1 and 88.8% in group 2 (*P*=0.398).

Discussion
==========

In the current study, we demonstrated that the primary macular hole closure and reattachment rates after PPV with the inverted ILM flap technique reached 100%, which were higher anatomic success rates compared with patients who underwent ILM peeling alone. In anatomical success rates, the statistical analysis differences were not determined, but patients who underwent the inverted ILM flap technique tended to achieve high anatomical success rates. Several groups reported the efficacy of ILM peeling as the initial procedure for MHRD.^[@bib13],\ [@bib14],\ [@bib24]^ In this procedure, the macular hole closure and reattachment rates were 10--91% and 70--92.3%, respectively. Our results showed higher anatomic success rates after PPV with the inverted ILM flap technique compared with previous reports.

ILM peeling allows total removal of the cortical vitreous and its components, contributing to complete relaxation of the retina. However, the retinal tension cannot be eliminated completely by ILM peeling, as some of the components, that is, vascular traction and posterior staphyloma, cannot be eliminated. ILM peeling alone may not compensate for macular hole closure in high myopia. Michalewska *et al* hypothesized that the inverted ILM flap technique stimulates proliferation of glial cells that fill the macular hole. In histopathologic findings, the ILM serves as a scaffold for gliosis.^[@bib25]^ One possibility is that proliferating glial cells may fill the macular hole and compensate for retinal shortening.

In terms of postoperative visual prognosis, the postoperative BCVA at 6 months after surgery and improvement of BCVA were significantly better in group 1 than in group 2. These results suggest that the proliferation of glial cells produces an environment conducive to the repositioning of photoreceptors in direct proximity to the fovea.

In a comparison of the inverted ILM flap technique and ILM peeling alone, Chen *et al*^[@bib26]^ reported that 23-gauge PPV with the inverted ILM flap technique contributed to better anatomical success. However, they found that there were no statistically significant differences in postoperative BCVA and improvement of BCVA between the inverted ILM flap technique and ILM peeling. One possibility to explain this is that their surgical procedures differed from ours. The difference may also have been due to the dyes used. Chen *et al*^[@bib26]^ used indocyanine green (ICG) as the adjuvant, and many researchers^[@bib27],\ [@bib28],\ [@bib29]^ reported the possible negative effects of ICG on visual outcome. Previously, other groups,^[@bib27],\ [@bib28]^ including ours,^[@bib30]^ reported that ICG staining may negatively affect the recovery of macular morphology and visual acuity after macular hole surgery. Baba *et al*^[@bib31]^ reported that the postoperative BCVA was better in eyes stained with BBG than in those stained with ICG, and the restoration of the ellipsoid zone was faster in eyes stained with BBG. In this procedure, the stained ILM flap comes into direct contact with the retinal pigment epithelium and remains stained over a long period. Therefore, we used BBG for the inverted ILM flap technique and ILM peeling alone.

In terms of anatomic success, our study showed that no significant differences were found in the anatomical success rates in both groups, but patients who underwent the inverted ILM flap technique achieved high anatomical success. An important problem is the possibility of the ILM flap moving away from the hole opening in the inverted ILM flap technique. Recently, Lai *et al*^[@bib32]^ have introduced the novel technique of using autologous blood clots to stabilize and seal ILM flaps. That technique has shown high anatomic success rates and only requires patients with MHRD to remain in a facedown position for a short time postoperatively. Lai *et al*^[@bib32]^ found that blood clots seal the holes after application and that the blood components and growth factors also facilitate healing. However, our study showed excellent anatomic success rates without the use of autologous blood clots. Further investigations are required to determine whether autologous blood clot application is effective in combination with the inverted ILM flap technique.

This study had certain limitations. The number of eyes was relatively small, the study was retrospective, and the follow-up period was short. Consequently, further studies are needed to confirm these results. In conclusion, the inverted ILM flap technique is a useful procedure for MHRD in highly myopic eyes and may become the standard treatment in the future.
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![(a) A 64-year-old man presented with MHRD. OCT demonstrated a macular hole and retinal detachment within the arcade (top left). The initial BCVA was 20/40. Using primary 25-gauge PPV with the inverted ILM flap technique, the ILM was inverted. Six months after surgery, the retina was reattached and the macular hole closed (bottom left). Postoperative BCVA was 20/40. (b) A 71-year-old woman presented with MHRD. OCT demonstrated a macular hole and retinal detachment beyond the arcade (top right). The initial BCVA was 4/200. Using primary 25-gauge PPV with the inverted ILM flap technique, the ILM was inverted. One month after surgery, the retina was reattached and the macular hole closed (bottom right). Postoperative BCVA improved to 16/200.](eye2016263f1){#fig1}

###### Patient characteristics

  *Patient no.*    *Age*   *Gender*   *Eye*   *Duration of symptoms (weeks)*  *Preoperative lens status*    *Axial length (μm)*  *Operative procedure*    *Inverted ILM flap*   *Tamponade*   *Preoperative BCVA (decimal)*
  --------------- ------- ---------- ------- -------------------------------- ---------------------------- --------------------- ----------------------- --------------------- ------------- -------------------------------
  1                 78        F         R                   28                Phakic                               27.14         PPV, PEA, IOL                     −             C~3~F~8~                 0.09
  2                 71        F         R                   16                IOL                                  27.24         PPV                              \+               SF~6~                  0.02
  3                 77        F         R                   24                IOL                                  28.49         PPV                               −               SF~6~                  0.02
  4                 50        F         L                   8                 IOL                                  31.22         PPV                               −             C~3~F~8~                  0.5
  5                 74        F         L                   2                 Phakic                               28.72         PPV, PEA, IOL                     −             C~3~F~8~                 0.04
  6                 77        F         R                   4                 Phakic                               31.61         PPV, PEA, IOL                    \+             C~3~F~8~                 0.03
  7                 82        F         R                   4                 IOL                                  28.34         PPV                              \+               SF~6~                   0.3
  8                 64        M         R                   4                 Phakic                               29.74         PPV                              \+               SF~6~                   0.5
  9                 68        M         R                   2                 IOL                                  31.14         PPV                               −             C~3~F~8~                 0.05
  10                74        F         L                   16                IOL                                  29.14         PPV                               −             C~3~F~8~                 0.09
  11                73        F         R                   48                IOL                                  31.4          PPV                               −             C~3~F~8~                  0.3
  12                46        F         R                   6                 IOL                                  30.06         PPV                               −             C~3~F~8~                  0.2
  13                79        F         L                   1                 IOL                                  34.37         PPV                              \+               SF~6~                  0.06
  14                54        M         R                   4                 Phakic                               33.63         PPV, PEA, IOL                     −               SF~6~                   0.1
  15                77        F         L                   12                IOL                                  31.56         PPV                              \+             C~3~F~8~                  0.1

Abbreviations: BCVA, best-corrected visual acuity; C~3~F~8~, perfluoropropane; F, female; ILM, internal limiting membrane; IOL, intraocular lens; M, male; PPV, pars plana vitrectomy; PEA, phacoemulsification; SF~6~, sulfur hexafluoride.

###### Comparison of preoperative study participant data (group 1=inverted ILM flap technique; group 2=ILM peeling)

  *Characteristics*                                                   *Group 1*    *Group 2*    P-*value*
  ------------------------------------------------------------------ ------------ ------------ -----------
  No. of patients                                                         6            9             
  Age (years; mean±SD)                                                 75.0±6.4    66.0±12.5      0.125
  Gender (male/female)                                                   1/5          2/7            
  Duration of symptoms (week; mean±SD)                                 6.8±5.8      11.3±9.5      0.376
                                                                                               
  *Preoperative lens status*                                                                   
   Phakic                                                                 2            3             
   Pseudophakic                                                           4            6             
  Preoperative RD status (within the archades/beyond the archades)       1/5          3/6            
  Axial length (mm; mean±SD)                                          30.47±2.57   30.10±1.95     0.637
                                                                                               
  *Tamponade*                                                                                  
   C~3~F~8~                                                               1            6             
   SF~6~                                                                  5                          
  Preoperative BCVA (logMAR; mean±SD)                                 1.04±0.55    1.00±0.44      0.906

Abbreviations: BCVA, best-corrected visual acuity; C~3~F~8~, perfluoropropane; ILM, internal limiting membrane; logMAR, logarithm of minimum angle of resolution; RD, retinal detachment; SF~6~, sulfur hexafluoride.

###### Comparison of postoperative study participant data (group 1=inverted ILM flap technique; group 2=ILM peeling)

  *Characteristics*                        *Group 1*     *Group 2*     P*-value*
  ---------------------------------------- ------------- ------------- -----------
  *Postoperative BCVA (logMAR; mean±SD)*                               
   1 month                                 0.95±0.30     1.05±0.38     0.68
   3 months                                0.83±0.22     1.06±0.49     0.238
   6 months                                0.62±0.35     1.02±0.41     0.045
  Improvement in BCVA                      --0.41±0.29   0.02±0.36     0.021
  Primary MH closure rate                  100% (6/6)    55.5% (5/9)   0.056
  Final MH closure rate                    100% (6/6)    88.8% (8/9)   0.398
  Primary retinal reattachment rate        100% (6/6)    55.5% (5/9)   0.056
  Final reattachment rate                  100% (6/6)    88.8% (8/9)   0.398

Abbreviations: BCVA, best-corrected visual acuity; ILM, internal limiting membrane; logMAR, logarithm of minimum angle of resolution MH, macular hole.
